Yüklüyor......
Loss of ARID1A Expression as a Favorable Prognostic Factor in Early-Stage Grade 3 Endometrioid Endometrial Carcinoma Patients
Introduction: High-risk patients with grade 3 endometrioid endometrial carcinoma (G3EEC) who require adjuvant therapy have not been clearly identified. Therefore, the current study aimed to investigate the prognostic impact of ARID1A, p53, and mismatch repair (MMR) protein expressions, previously re...
Kaydedildi:
| Yayımlandı: | Pathol Oncol Res |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8262237/ https://ncbi.nlm.nih.gov/pubmed/34257552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/pore.2021.598550 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|